Novo Holdings A/s - Net Worth and Insider Trading
Novo Holdings A/s Net Worth
The estimated net worth of Novo Holdings A/s is at least $1.7 Billion dollars as of 2024-10-10. Novo Holdings A/s is the 10% Owner of Arcellx Inc and owns about 4,016,878 shares of Arcellx Inc (ACLX) stock worth over $333 Million. Novo Holdings A/s is the 10% Owner of Edgewise Therapeutics Inc and owns about 6,071,703 shares of Edgewise Therapeutics Inc (EWTX) stock worth over $184 Million. Novo Holdings A/s is also the 10% Owner of Morphic Holding Inc and owns about 2,645,446 shares of Morphic Holding Inc (MORF) stock worth over $151 Million. Besides these, Novo Holdings A/s also holds Harmony Biosciences Holdings Inc (HRMY) , CoLucid Pharmaceuticals Inc (CLCD) , iRhythm Technologies Inc (IRTC) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , AnaptysBio Inc (ANAB) , Disc Medicine Inc (IRON) , Inogen Inc (INGN) , Checkmate Pharmaceuticals Inc (CMPI) , Flexion Therapeutics Inc (FLXN) , Apollo Endosurgery Inc (APEN) , Inozyme Pharma Inc (INZY) , Nkarta Inc (NKTX) , Cyteir Therapeutics Inc (CYTT) , Corvus Pharmaceuticals Inc (CRVS) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Milestone Pharmaceuticals Inc (MIST) , Verve Therapeutics Inc (VERV) , Metagenomi Inc (MGX) , Bolt Biotherapeutics Inc (BOLT) , Spruce Biosciences Inc (SPRB) , Aligos Therapeutics Inc (ALGS) , Galecto Inc (GLTO) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) . Details can be seen in Novo Holdings A/s's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Novo Holdings A/s has not made any transactions after 2024-07-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Novo Holdings A/s
Novo Holdings A/s Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Novo Holdings A/s owns 41 companies in total, including Praxis Precision Medicines Inc (PRAX) , Eargo Inc (EAR) , and Aligos Therapeutics Inc (ALGS) among others .
Click here to see the complete history of Novo Holdings A/s’s form 4 insider trades.
Insider Ownership Summary of Novo Holdings A/s
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
PRAX | Praxis Precision Medicines Inc | 2020-10-15 | 10 percent owner |
EAR | Eargo Inc | 2020-10-20 | 10 percent owner |
ALGS | Aligos Therapeutics Inc | 2020-10-20 | 10 percent owner |
2021-02-18 | 10 percent owner & other: SEE REMARKS | ||
2024-03-21 | 10 percent owner | ||
2020-08-21 | 10 percent owner | ||
2022-02-25 | 10 percent owner | ||
2021-01-28 | 10 percent owner | ||
2020-07-14 | 10 percent owner | ||
2020-07-08 | 10 percent owner | ||
2019-11-25 | 10 percent owner & other: SEE REMARKS | ||
2019-07-22 | 10 percent owner | ||
2019-06-28 | 10 percent owner | ||
2018-09-28 | 10 percent owner | ||
2017-10-12 | 10 percent owner | ||
2017-08-25 | 10 percent owner | ||
2017-08-21 | 10 percent owner | ||
2017-07-26 | 10 percent owner | ||
2017-06-14 | 10 percent owner | ||
2016-12-15 | 10 percent owner & other: SEE REMARKS | ||
2016-10-31 | 10 percent owner | ||
2016-10-25 | 10 percent owner | ||
2016-09-09 | 10 percent owner | ||
2016-07-11 | 10 percent owner | ||
2015-06-22 | 10 percent owner | ||
2014-11-05 | 10 percent owner & other: SEE REMARKS | ||
2021-03-01 | 10 percent owner & other: SEE REMARKS | ||
2014-08-12 | 10 percent owner & other: SEE REMARKS | ||
2014-06-23 | 10 percent owner & other: See Remarks | ||
2014-05-13 | 10 percent owner & other: SEE REMARKS | ||
2014-03-19 | 10 percent owner & other: SEE REMARKS | ||
2021-10-26 | 10 percent owner | ||
2023-06-23 | 10 percent owner | ||
2022-07-13 | 10 percent owner | ||
2023-07-20 | 10 percent owner | ||
2022-09-14 | 10 percent owner | ||
2022-02-08 | 10 percent owner | ||
2020-11-02 | 10 percent owner | ||
2021-06-21 | 10 percent owner | ||
2024-07-26 | 10 percent owner | ||
2023-06-28 | 10 percent owner |
Novo Holdings A/s Latest Holdings Summary
Novo Holdings A/s currently owns a total of 37 stocks. Among these stocks, Novo Holdings A/s owns 4,016,878 shares of Arcellx Inc (ACLX) as of February 8, 2022, with a value of $333 Million and a weighting of 19.33%. Novo Holdings A/s owns 6,071,703 shares of Edgewise Therapeutics Inc (EWTX) as of September 14, 2022, with a value of $184 Million and a weighting of 10.68%. Novo Holdings A/s also owns 2,645,446 shares of Morphic Holding Inc (MORF) as of June 28, 2019, with a value of $151 Million and a weighting of 8.75%. The other 34 stocks Harmony Biosciences Holdings Inc (HRMY) , CoLucid Pharmaceuticals Inc (CLCD) , iRhythm Technologies Inc (IRTC) , Reata Pharmaceuticals Inc (RETA) , Ra Pharmaceuticals Inc (RARX) , Mirum Pharmaceuticals Inc (MIRM) , Tobira Therapeutics Inc (TBRA) , AnaptysBio Inc (ANAB) , Disc Medicine Inc (IRON) , Inogen Inc (INGN) , Checkmate Pharmaceuticals Inc (CMPI) , Flexion Therapeutics Inc (FLXN) , Apollo Endosurgery Inc (APEN) , Inozyme Pharma Inc (INZY) , Nkarta Inc (NKTX) , Cyteir Therapeutics Inc (CYTT) , Corvus Pharmaceuticals Inc (CRVS) , Reneo Pharmaceuticals Inc (RPHM) , IO Biotech Inc (IOBT) , Entasis Therapeutics Holdings Inc (ETTX) , Milestone Pharmaceuticals Inc (MIST) , Verve Therapeutics Inc (VERV) , Metagenomi Inc (MGX) , Bolt Biotherapeutics Inc (BOLT) , Spruce Biosciences Inc (SPRB) , Aligos Therapeutics Inc (ALGS) , Galecto Inc (GLTO) , Galera Therapeutics Inc (GRTX) , Eargo Inc (EAR) , Minerva Surgical Inc (UTRS) , Cold Metal Products Inc (CMPI) , KalVista Pharmaceuticals Inc (KALV) , HTG Molecular Diagnostics Inc (HTGMQ) , IVERIC bio Inc (ISEE) have a combined weighting of 61.24% among all his current holdings.
Latest Holdings of Novo Holdings A/s
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACLX | Arcellx Inc | 2022-02-08 | 4,016,878 | 82.96 | 333,240,199 |
EWTX | Edgewise Therapeutics Inc | 2022-09-14 | 6,071,703 | 30.33 | 184,154,752 |
MORF | Morphic Holding Inc | 2019-06-28 | 2,645,446 | 56.99 | 150,763,968 |
HRMY | Harmony Biosciences Holdings Inc | 2020-08-21 | 4,409,803 | 33.61 | 148,213,479 |
CLCD | CoLucid Pharmaceuticals Inc | 2016-09-09 | 3,156,563 | 46.53 | 146,859,094 |
IRTC | iRhythm Technologies Inc | 2016-10-25 | 2,124,448 | 58.67 | 124,641,364 |
RETA | Reata Pharmaceuticals Inc | 2017-06-14 | 592,794 | 172.36 | 102,173,974 |
RARX | Ra Pharmaceuticals Inc | 2016-10-31 | 2,031,562 | 47.99 | 97,494,660 |
MIRM | Mirum Pharmaceuticals Inc | 2019-07-22 | 2,445,147 | 37.85 | 92,548,814 |
TBRA | Tobira Therapeutics Inc | 2016-07-13 | 1,875,905 | 42.09 | 78,956,841 |
ANAB | AnaptysBio Inc | 2017-08-21 | 1,936,604 | 31.45 | 60,906,196 |
IRON | Disc Medicine Inc | 2023-06-28 | 1,090,772 | 46.77 | 51,015,406 |
INGN | Inogen Inc | 2021-03-01 | 2,759,320 | 9.00 | 24,833,880 |
CMPI | Checkmate Pharmaceuticals Inc | 2022-02-25 | 2,161,990 | 10.50 | 22,700,895 |
FLXN | Flexion Therapeutics Inc | 2015-06-22 | 2,133,131 | 9.12 | 19,454,155 |
APEN | Apollo Endosurgery Inc | 2017-07-26 | 1,301,842 | 10.00 | 13,018,420 |
INZY | Inozyme Pharma Inc | 2021-01-28 | 2,194,379 | 5.11 | 11,213,277 |
NKTX | Nkarta Inc | 2020-07-14 | 2,793,865 | 3.94 | 11,007,828 |
CYTT | Cyteir Therapeutics Inc | 2023-07-20 | 3,522,136 | 3.01 | 10,601,629 |
CRVS | Corvus Pharmaceuticals Inc | 2020-07-08 | 1,389,498 | 5.99 | 8,323,093 |
RPHM | Reneo Pharmaceuticals Inc | 2023-06-23 | 333,034 | 18.20 | 6,061,219 |
IOBT | IO Biotech Inc | 2024-07-26 | 4,354,449 | 1.10 | 4,789,894 |
ETTX | Entasis Therapeutics Holdings Inc | 2018-09-28 | 2,181,843 | 2.19 | 4,778,236 |
MIST | Milestone Pharmaceuticals Inc | 2019-11-25 | 2,434,470 | 1.50 | 3,651,705 |
VERV | Verve Therapeutics Inc | 2021-06-21 | 793,265 | 4.57 | 3,625,221 |
MGX | Metagenomi Inc | 2024-02-13 | 1,739,175 | 1.95 | 3,391,391 |
BOLT | Bolt Biotherapeutics Inc | 2022-07-13 | 3,703,991 | 0.64 | 2,370,554 |
SPRB | Spruce Biosciences Inc | 2024-03-21 | 2,550,000 | 0.43 | 1,083,750 |
ALGS | Aligos Therapeutics Inc | 2020-10-20 | 104,583 | 7.76 | 811,564 |
GLTO | Galecto Inc | 2020-11-02 | 99,912 | 7.16 | 715,370 |
GRTX | Galera Therapeutics Inc | 2021-02-18 | 2,459,021 | 0.07 | 181,968 |
EAR | Eargo Inc | 2020-10-20 | 44,354 | 2.57 | 113,990 |
UTRS | Minerva Surgical Inc | 2021-10-26 | 102,857 | 0.01 | 1,234 |
CMPI | Cold Metal Products Inc | 2020-08-11 | 2,170,100 | 0.00 | 0 |
KALV | KalVista Pharmaceuticals Inc | 2017-10-12 | 0 | 11.25 | 0 |
HTGMQ | HTG Molecular Diagnostics Inc | 2017-08-25 | 0 | 0.00 | 0 |
ISEE | IVERIC bio Inc | 2016-12-15 | 0 | 39.95 | 0 |
Holding Weightings of Novo Holdings A/s
Novo Holdings A/s Form 4 Trading Tracker
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 1 transactions in Arcellx Inc (ACLX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Arcellx Inc is the acquisition of 833,333 shares on February 8, 2022, which cost Novo Holdings A/s around $13 Million.
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 2 transactions in Edgewise Therapeutics Inc (EWTX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Edgewise Therapeutics Inc is the acquisition of 484,496 shares on September 14, 2022, which cost Novo Holdings A/s around $5 Million.
According to the SEC Form 4 filings, Novo Holdings A/s has made a total of 0 transactions in Morphic Holding Inc (MORF) over the past 5 years. The most-recent trade in Morphic Holding Inc is the acquisition of 666,667 shares on June 28, 2019, which cost Novo Holdings A/s around $10 Million.
More details on Novo Holdings A/s's insider transactions can be found in the Insider Trading History of Novo Holdings A/s table.Insider Trading History of Novo Holdings A/s
- 1
Novo Holdings A/s Trading Performance
GuruFocus tracks the stock performance after each of Novo Holdings A/s's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Novo Holdings A/s is 3.33%. GuruFocus also compares Novo Holdings A/s's trading performance to market benchmark return within the same time period. The performance of stocks bought by Novo Holdings A/s within 3 months outperforms 15 times out of 37 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Novo Holdings A/s's insider trading performs compared to the benchmark.
Performance of Novo Holdings A/s
Novo Holdings A/s Ownership Network
Novo Holdings A/s Owned Company Details
What does Praxis Precision Medicines Inc do?
Who are the key executives at Praxis Precision Medicines Inc?
Novo Holdings A/s is the 10 percent owner of Praxis Precision Medicines Inc. Other key executives at Praxis Precision Medicines Inc include Chief Executive Officer Marcio Souza , Chief Financial Officer Timothy Edwin Kelly , and Principal Accounting Officer Lauren Mastrocola .
Praxis Precision Medicines Inc (PRAX) Insider Trades Summary
Over the past 18 months, Novo Holdings A/s made no insider transaction in Praxis Precision Medicines Inc (PRAX). Other recent insider transactions involving Praxis Precision Medicines Inc (PRAX) include a net purchase of 14,500 shares made by Jill Desimone , and a net purchase of 10,000 shares made by Marcio Souza .
In summary, during the past 3 months, insiders sold 0 shares of Praxis Precision Medicines Inc (PRAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Praxis Precision Medicines Inc (PRAX) were sold and 1,633 shares were bought by its insiders, resulting in a net purchase of 1,633 shares.
Praxis Precision Medicines Inc (PRAX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Praxis Precision Medicines Inc Insider Transactions
Novo Holdings A/s Mailing Address
Above is the net worth, insider trading, and ownership report for Novo Holdings A/s. You might contact Novo Holdings A/s via mailing address: Tuborg Havnevej 19, Hellerup G7 2900.